WAVE Life Sciences Ltd (FRA:1U5)
€ 12.8 -0.1 (-0.78%) Market Cap: 1.89 Bil Enterprise Value: 1.62 Bil PE Ratio: 0 PB Ratio: 13.52 GF Score: 41/100

WAVE Life Sciences Ltd Analyst And Investor Research Corporate Call Transcript

Sep 28, 2021 / 02:00PM GMT
Release Date Price: €5.07 (-0.12%)
Operator

(technical difficulty) (Operator Instructions) It is now my pleasure to turn today's program over to Kate Rausch, Head of Investor Relations at Wave Life Sciences. Please go ahead.

Kate Rausch
Wave Life Sciences Ltd. - Head of IR

Thank you, operator. Good morning, and welcome to Wave's 2021 Analyst and Investor Research Webcast. The slides that accompany today's presentation will be available in the Investors section of our website at www.wavelifesciences.com following the webcast.

Before we begin, I would like to remind you that management may make forward-looking statements during today's presentation. These statements are subject to a number of risks and uncertainties that could cause our actual results to differ materially from those described in these forward-looking statements. The factors that could cause actual results to differ are discussed in our SEC filings, including our annual report on Form 10-K for the year ended December 31, 2020, and our quarterly report on Form

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot